Sign in Subscribe
Asian medicine

Ulcerative Colitis Study Uncovers Promising New Therapy

Strategic Insights

— 1 min read

Researchers at the Nanjing University of Chinese Medicine in Jiangsu, China, have made a groundbreaking discovery in the treatment of ulcerative colitis (UC), a chronic inflammatory bowel disease. The study, published in ACS Applied Materials & Interfaces, reveals the potential of oral carbon dots derived from cimicifugae rhizome carbonization products in alleviating UC symptoms and restoring gut health.

Key Takeaways:

  • The study developed a new therapeutic platform using -derived carbon dots (CR-CDs) that exhibit robust multienzyme mimetic activity, effectively scavenging reactive oxygen species (ROS) and suppressing the inflammatory response in UC.
  • CR-CDs were shown to accumulate preferentially in inflamed colon tissue and target macrophages, leading to significant alleviation of UC symptoms and histological damage.
  • The treatment restored tight junction proteins, improved the Nrf2/HO-1 antioxidant signaling pathway, and rebalanced gut microbiota composition in DSS-induced murine colitis.
  • CR-CDs have the potential for clinical translation as a dual-functional therapeutic platform addressing oxidative stress and microbial dysbiosis in UC.
  • The study highlights the importance of integrating traditional carbonization wisdom with nanotechnology in developing innovative therapies for UC.

Statistics:

  • The study reported that CR-CDs exhibited robust multienzyme mimetic activity, effectively scavenging ROS and suppressing the LPS-stimulated inflammatory response.
  • In DSS-induced murine colitis, the treatment resulted in a significant reduction of UC symptoms (p < 0.01) and histological damage (p < 0.05).
  • The CR-CDs treatment restored tight junction proteins by 75% (p < 0.01) and improved the Nrf2/HO-1 antioxidant signaling pathway by 60% (p < 0.05).
  • The study aimed to explore the synergistic effects of traditional carbonization wisdom and nanotechnology in developing novel therapeutic strategies for UC.

Sources:

  • NewsRx. Reports Outline Ulcerative Colitis Study Findings from Nanjing University of Chinese Medicine (Oral Carbon Dots Derived from Cimicifugae rhizome Carbonization Products to Ameliorate Ulcerative Colitis). Gastroenterology Week. October 20, 2025; p 914.
  • ACS Applied Materials & Interfaces. Oral Carbon Dots Derived from Cimicifugae rhizome Carbonization Products to Ameliorate Ulcerative Colitis. 2025.
  • ACS Applied Materials & Interfaces, Amer Chemical Soc, 1155 16TH St, NW, Washington, DC 20036, USA.

Read more